SGEN

Are Biotech Stocks Nearing Exhaustion… Again? | See It Market

In early April I wrote a piece arguing that biotech stocks – using the iShares Nasdaq Biotech ETF (IBB) as a proxy – looked to be under distribution. At the time the IBB traded at approximately $340. My argument rested on negative divergences in the Shares Outstanding / Price action of the IBB, Block Money Flow trends, an increase in volatility, […]

Seattle Genetics to Present at Upcoming Investor Conferences

[Business Wire] – Seattle Genetics, Inc. announced today that management will present at the following upcoming investor conferences. The presentations will be webcast live and availab moreView todays social media effects on SGENView the latest stocks trending across Twitter. Click to view dashboardSee who Seattle is hiring next, click here to view […]

Narrower-than-Expected Loss at Seattle Genetics

moreView todays social media effects on SGENView the latest stocks trending across Twitter. Click to view dashboardSee who Seattle is hiring next, click here to view […]

Seattle Genetics Management Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Christopher S. Boerner Thanks, Clay. ADCETRIS net sales in the first quarter were $38.7 million, which represents a modest increase over Q4. The underlying dynamics of the U.S. business remained favorable … moreView todays social media effects on SGENView the latest stocks trending across Twitter. Click to view dashboardSee who Seattle is hiring next, click here […]